Taking everything into account, TECH scores 6 out of 10 in our fundamental rating. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH has a correct valuation and a medium growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROIC | 9.33% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Altman-Z | 12.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.07 | ||
| Fwd PE | 27.9 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.38 | ||
| EV/EBITDA | 26.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
63.82
+0.87 (+1.38%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.07 | ||
| Fwd PE | 27.9 | ||
| P/S | 8.17 | ||
| P/FCF | 44.38 | ||
| P/OCF | 39.58 | ||
| P/B | 5.06 | ||
| P/tB | 15.62 | ||
| EV/EBITDA | 26.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.04% | ||
| ROE | 3.91% | ||
| ROCE | 11.3% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.93% | ||
| ROICexgc | 24.48% | ||
| OM | 22.13% | ||
| PM (TTM) | 6.32% | ||
| GM | 66.83% | ||
| FCFM | 18.41% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.34 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 25.63% | ||
| Cap/Sales | 2.24% | ||
| Interest Coverage | 14.5 | ||
| Cash Conversion | 66.94% | ||
| Profit Quality | 291.58% | ||
| Current Ratio | 4.22 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 12.16 |
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.